Liu Qiang, Chairman of YaoPharma, said: "By leveraging Pfizer's exceptional global development experience and commercialisation network, along with YaoPharma's profound expertise in small molecule R&D and manufacturing, our shared goal is to accelerate the global development and commercialisation of this innovative drug, thereby benefiting patients worldwide more rapidly and extensively." Pfizers moves with Metsera and now YaoPharma add to continued competition in the obesity drug market, which has also seen Teva Pharmaceuticals gain US Food and Drug Administration (FDA) approval in August of a generic GLP-1 of its version of Novo Nordisks injectable Saxenda (liraglutide).
Storage: Store at 2-8C
Ze worden veroorzaakt door verschillende factoren zoals bacterin, virussen, straling, zware metalen, bepaalde medicijnen en veroudering
Ive always exercised like I lift weights at the gym. Related stories: A diagnosis at 29 for Polycystic Ovary Syndrome (PCOS), which can impact weight due to insulin resistance and hormone imbalances, alludes to a possible cause
If anything does not look right, check with a doctor or pharmacist before taking the medicine